Viewing nowAprogen Rosuvastatin Calcium Tablet 10mg
Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Aprogen BioLogics Co., Ltd.

MFDS item code 201403200 · Approved 2014.07.17 · Insurance code 645208330
Improvement of dyslipidemia; inhibition of atherosclerosis progression; prevention of cardiovascular disease
This medication is used as an adjunct therapy in patients with primary hypercholesterolemia and mixed dyslipidemia who are unable to control their condition through diet and exercise. It can also be administered as an adjunct to dietary changes and other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. This drug helps lower total cholesterol and LDL-cholesterol levels, delaying the progression of atherosclerosis. It is also used as an adjunct to dietary therapy in patients with primary dysbetalipoproteinemia. Furthermore, it contributes to reducing the risk of stroke, myocardial infarction, and arterial revascularization in middle-aged men and women at high risk for cardiovascular disease. It is used for various dyslipidemias and cardiovascular risk reduction.
1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: Systemic exposure to rosuvastatin was not increased in patients with a Child-Pugh score of 7 or less, but was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Ethnicity: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
This drug should not be administered to certain patients. For example, patients who are allergic to this drug or have severely impaired liver function, patients with muscle disorders, patients taking specific medications, patients with severe renal impairment, and women who are pregnant or breastfeeding should not use this medication. Additionally, high-dose use is prohibited for patients at risk of muscle-related disorders. Patients with lactose intolerance should also avoid taking this medication. Care should be taken when using this drug in individuals with a history of liver disease or heavy alcohol consumption. It is advisable to repeat liver function tests before and during treatment. In cases of specific conditions such as hypothyroidism or nephrotic syndrome, treatment of those conditions should be performed first. Muscle-related side effects, such as myalgia, muscle weakness, and, rarely, serious muscle damage, have been reported, so patients should promptly inform their doctor and get tested if they experience myalgia or muscle weakness. If there is a significant increase in muscle enzyme levels, it may be necessary to discontinue the medication. This drug can also affect liver function, potentially leading to increased liver enzyme levels. If symptoms of liver dysfunction arise, immediate consultation with a healthcare professional is necessary. Rarely, this drug can cause side effects such as skin rash, hives, or severe skin reactions, so if abnormal skin symptoms occur, treatment should be discontinued immediately, and the patient should go to a hospital. Interactions may occur when taken with other medications, particularly when combined with certain antivirals, immunosuppressants, some antibiotics, and fibrate class drugs, so caution is needed. Pregnant women or women who may become pregnant should not take this medication and should use appropriate contraceptive methods. Breastfeeding mothers should also avoid taking this medication. There is no specific antidote for overdose, so treatment should be symptomatic, and careful monitoring of liver function and muscle enzyme levels is required. This medication may cause dizziness, so caution is needed when driving or operating machinery. While taking this medication, it is important to undergo regular check-ups as directed by a physician and to consult with healthcare professionals immediately if side effects occur.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, sensory disturbances, discomfort in the chest, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and humidity, so it should be stored in a tightly closed container. It is also recommended to store it at room temperature, not too cold or too hot, ideally between 1 degree and 30 degrees Celsius.
Pink round film-coated tablet
For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Aprogen BioLogics Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Daiwoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.